MK-6096 (Filorexant)
MK6096,也被称为filorexant,是一种口服生物利用度高的强效且选择性的可逆OX(1)R和OX(2)R拮抗剂,目前正处于失眠症的临床开发阶段。MK-6096展示了对人类OX(1)R和OX(2)R的强效结合和拮抗作用(结合力<3 nM,FLIPR中11 nM),并且在超过170种受体和酶的检测中没有显著的非目标活性。
| Discription | MK6096, also known as filorexant, is an orally bioavailable potent and selective reversible antagonist of OX(1)R and OX(2)R currently in clinical development for insomnia. MK-6096 demonstrated potent binding and antagonism of both human OX(1)R and OX(2)R (<3 nM in binding, 11 nM in FLIPR), with no significant off-target activities against a panel of >170 receptors and enzymes. | |||||
|---|---|---|---|---|---|---|
| Cell Research |
|
| 目录号 | A13168 |
|---|---|
| 分子式 | C24H25FN4O2 |
| 分子量 | 420.48 |
| CAS号 | 1088991-73-4 |
| SMILES | CC1=CC=C(C2=NC=CC=N2)C(C(N3C[C@@H](COC4=NC=C(F)C=C4)CC[C@@H]3C)=O)=C1 |
| 其他名称 | MK6096, MK-6096, MK 6096 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2